BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 17, 2020
View Archived Issues
Lifespan synaptic atlas gives developmental insights
Read More
Prozac for infectious disease
Read More
Staten begins first-in-human study of STT-5058 for hypertriglyceridemia
Read More
Phase IIa data reported for Sym-015 in non-small cell lung cancer patients
Read More
KAND-567 demonstrates positive effect on mobility in a preclinical model of spinal cord injury
Read More
MK-1092 demonstrates safety and promising glucose-lowering activity
Read More
Phase Ib data for ningetinib and gefitinib in EGFR-TKI-resistant NSCLC
Read More
Positive data reported from phase II AFFIRM-35 study of ABY-035
Read More
First patient dosed in dose-expansion stage of phase Ib/II trial of cavrotolimod
Read More
Bisantrene phase II study in AML yields positive results
Read More
Pfizer describes new hemoglobin subunit beta polymerization inhibitors
Read More
New PCSK9 inhibitors discovered at Novartis
Read More
BioVersys synthesizes compounds interacting with accessory gene regulator A
Read More
Vyome releases positive phase II results for VB-1953
Read More
3M Pharmaceuticals patents cytokine biosynthesis inducers
Read More
Netakimab demonstrates superiority to placebo in second-line psoriatic arthritis
Read More
TOPADUR Pharma presents dual PDE5A inhibitors/soluble guanylate cyclase activators
Read More
Health Canada approves initiation of COVID-19 study of EB-05
Read More
New therapeutic target identified for emphysema in COPD
Read More
Syndrome with oculo-cerebral anomalies connected to PLXNA1 gene variants
Read More
Ilaris approved in U.S. for active Still's disease
Read More
FDA approves Cosentyx for active nonradiographic axial spondyloarthritis
Read More
FDA clears start of phase II trial of Metablok to prevent acute lung and kidney injury in COVID-19
Read More
Phase I results reported for BTK inhibitor TG-1701 in relapsed/refractory B-cell malignancies
Read More
Phase II study of APG-1387 for chronic hepatitis B doses first patient
Read More
FDA accepts IND for investigator-initiated trial of ATI-450 in hospitalized patients with COVID-19
Read More
Sinopharm's COVID-19 vaccine produces high-titer antibodies in phase I/II study
Read More
FDA allows Hookipa to study HB-202 with HB-201 for HPV-positive cancers
Read More
FDA clears initiation of phase II/III study of PTC-299 for COVID-19
Read More